Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.55+0.63 (+4.53%)
Close on Nov 18, 2026Market cap $1.05BP/E –Yield –
Omeros operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Omeros's operating income for the twelve months ending Jun 30, 2026 was -$72.82M. For fiscal 2025 it was -$122.80M. The highest annual figure on record is -$20.76M in fiscal 2009.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$122.80M | – |
| FY2024 | Dec 31, 2024 | -$166.95M | – |
| FY2023 | Dec 31, 2023 | -$164.53M | – |
| FY2022 | Dec 31, 2022 | -$163.39M | – |
| FY2021 | Dec 31, 2021 | -$173.62M | – |
| FY2020 | Dec 31, 2020 | -$156.92M | – |
| FY2019 | Dec 31, 2019 | -$146.04M | – |
| FY2018 | Dec 31, 2018 | -$112.22M | – |
| FY2017 | Dec 31, 2017 | -$43.90M | – |
| FY2016 | Dec 31, 2016 | -$54.28M | – |
| FY2015 | Dec 31, 2015 | -$71.24M | – |
| FY2014 | Dec 31, 2014 | -$70.01M | – |
| FY2013 | Dec 31, 2013 | -$50.52M | – |
| FY2012 | Dec 31, 2012 | -$36.89M | – |
| FY2011 | Dec 31, 2011 | -$27.41M | – |
| FY2010 | Dec 31, 2010 | -$30.11M | – |
| FY2009 | Dec 31, 2009 | -$20.76M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $74.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.42M | – |
| Q4 FY2025 | Dec 31, 2025 | -$29.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$26.39M | – |
| Q2 FY2025 | Jun 30, 2025 | -$32.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$34.97M | – |
| Q4 FY2024 | Dec 31, 2024 | -$33.36M | – |
| Q3 FY2024 | Sep 30, 2024 | -$35.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$59.16M | – |
| Q1 FY2024 | Mar 31, 2024 | -$39.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$39.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$48.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$40.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$35.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$40.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$50.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$37.44M | – |
| Q1 FY2022 | Mar 31, 2022 | -$35.05M | – |
| Q4 FY2021 | Dec 31, 2021 | -$42.89M | – |
| Q1 FY2021 | Mar 31, 2021 | -$45.29M | – |
| Q4 FY2020 | Dec 31, 2020 | -$33.82M | – |
| Q3 FY2020 | Sep 30, 2020 | -$25.43M | – |
| Q2 FY2020 | Jun 30, 2020 | -$27.68M | – |
| Q1 FY2020 | Mar 31, 2020 | -$23.68M | – |
| Q4 FY2019 | Dec 31, 2019 | -$23.70M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.10M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.34M | – |
| Q1 FY2019 | Mar 31, 2019 | -$19.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.47M | – |
| Q3 FY2018 | Sep 30, 2018 | -$35.44M | – |
| Q2 FY2018 | Jun 30, 2018 | -$30.62M | – |
| Q1 FY2018 | Mar 31, 2018 | -$27.69M | – |
| Q4 FY2017 | Dec 31, 2017 | -$14.12M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.11M | – |
| Q2 FY2017 | Jun 30, 2017 | -$11.94M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.73M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.86M | – |
| Q3 FY2016 | Sep 30, 2016 | -$12.04M | – |
| Q2 FY2016 | Jun 30, 2016 | -$10.93M | – |
See a number that looks wrong?